{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T19:41:02Z","timestamp":1745782862128},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,4,14]],"date-time":"2009-04-14T00:00:00Z","timestamp":1239667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12032-009-9213-0","type":"journal-article","created":{"date-parts":[[2009,4,13]],"date-time":"2009-04-13T16:39:15Z","timestamp":1239640755000},"page":"327-331","source":"Crossref","is-referenced-by-count":1,"title":["Intensive chemotherapy failure in Burkitt\u2019s lymphoma with cavernous sinus involvement"],"prefix":"10.1007","volume":"27","author":[{"given":"Zhi-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Liang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,14]]},"reference":[{"key":"9213_CR1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1634\/theoncologist.11-4-375","volume":"11","author":"JA Ferry","year":"2006","unstructured":"Ferry JA. Burkitt\u2019s lymphoma: clinicopathologic features and differential diagnosis. Oncologist. 2006;11:375\u201383. doi: 10.1634\/theoncologist.11-4-375 .","journal-title":"Oncologist"},{"key":"9213_CR2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","volume":"98","author":"ES Wang","year":"2003","unstructured":"Wang ES, et al. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer. 2003;98:1196\u2013205. doi: 10.1002\/cncr.11628 .","journal-title":"Cancer"},{"key":"9213_CR3","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009\u201320. doi: 10.1182\/blood-2004-02-0405 .","journal-title":"Blood"},{"key":"9213_CR4","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1200\/JCO.2007.11.0700","volume":"25","author":"J Salzburg","year":"2007","unstructured":"Salzburg J, et al. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin\u2019s lymphoma differ by non-Hodgkin\u2019s lymphoma subtype: a Berlin-Frankfurt-Munster Group Report. J Clin Oncol. 2007;25:3915\u201322. doi: 10.1200\/JCO.2007.11.0700 .","journal-title":"J Clin Oncol"},{"key":"9213_CR5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","volume":"14","author":"I Magrath","year":"1996","unstructured":"Magrath I, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996;14:925\u201334.","journal-title":"J Clin Oncol"},{"key":"9213_CR6","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","volume":"17","author":"DA Thomas","year":"1999","unstructured":"Thomas DA, et al. Hyper-CVAD program in Burkitt\u2019s-type adult acute lymphoblastic leukemia. J Clin Oncol. 1999;17:2461\u201370.","journal-title":"J Clin Oncol"},{"key":"9213_CR7","first-page":"401","volume":"19","author":"EJ Lee","year":"2001","unstructured":"Lee EJ, et al. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol. 2001;19:401\u201322.","journal-title":"J Clin Oncol"},{"key":"9213_CR8","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","volume":"336","author":"LD Kaplan","year":"1997","unstructured":"Kaplan LD, et al. For the National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin\u2019s lymphoma associated with human immunodeficiency virus infection. N Engl J Med. 1997;336:1641\u20138. doi: 10.1056\/NEJM199706053362304 .","journal-title":"N Engl J Med"},{"key":"9213_CR9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: cotswolds meeting. J Clin Oncol. 1989;7:1630\u20136.","journal-title":"J Clin Oncol"},{"key":"9213_CR10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"MA Shipp","year":"1993","unstructured":"Shipp MA, et al. International non-Hodgkin\u2019s lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329:987\u201394. doi: 10.1056\/NEJM199309303291402 .","journal-title":"N Engl J Med"},{"key":"9213_CR11","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","volume":"106","author":"DA Thomas","year":"2006","unstructured":"Thomas DA, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569\u201380. doi: 10.1002\/cncr.21776 .","journal-title":"Cancer"},{"key":"9213_CR12","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1080\/1042819021000015998","volume":"43","author":"FL Ampil","year":"2002","unstructured":"Ampil FL, et al. Cavernous sinus involvement by extramedullary plasmacytoma of the sphenoid sinus. an argument for the use of adjuvant chemotherapy. Leuk Lymphoma. 2002;43:2037\u201340.","journal-title":"Leuk Lymphoma"},{"key":"9213_CR13","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/1042819021000003054","volume":"43","author":"I Broek Vande","year":"2002","unstructured":"Vande Broek I, et al. Extramedullary plasmacytoma of the cavernous sinus. Leuk Lymphoma. 2002;43:1691\u20133. doi: 10.1080\/1042819021000003054 .","journal-title":"Leuk Lymphoma"},{"key":"9213_CR14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3816\/CLM.2007.n.017","volume":"7","author":"A Gozzetti","year":"2007","unstructured":"Gozzetti A, et al. Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib. Clin Lymphoma Myeloma. 2007;7:376\u20138. doi: 10.3816\/CLM.2007.n.017 .","journal-title":"Clin Lymphoma Myeloma"},{"key":"9213_CR15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3109\/10428190109097736","volume":"42","author":"A Sanjeevi","year":"2001","unstructured":"Sanjeevi A, Krishnan J, Bailey PR, Catlett J. Extranodal marginal zone B-cell lymphoma of malt type involving the cavernous sinus. Leuk Lymphoma. 2001;42:1133\u20137. doi: 10.3109\/10428190109097736 .","journal-title":"Leuk Lymphoma"},{"key":"9213_CR16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00247-003-1010-x","volume":"33","author":"TA Huisman","year":"2003","unstructured":"Huisman TA, et al. Burkitt\u2019s lymphoma with bilateral cavernous sinus and mediastinal involvement in a child. Pediatr Radiol. 2003;33:719\u201321. doi: 10.1007\/s00247-003-1010-x .","journal-title":"Pediatr Radiol"},{"key":"9213_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.wno.0000177294.14351.6c","volume":"25","author":"MS Vaphiades","year":"2005","unstructured":"Vaphiades MS, Lee AG. Burkitt lymphoma presenting with gingival pain and a cavernous sinus syndrome in an adult. J Neuroophthalmol. 2005;25:249\u201350. doi: 10.1097\/01.wno.0000177294.14351.6c .","journal-title":"J Neuroophthalmol"},{"key":"9213_CR18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00001622-200409000-00003","volume":"16","author":"YL Kasamon","year":"2004","unstructured":"Kasamon YL, Swinnen LJ. Treatment advances in adult Burkitt lymphoma and leukemia. Curr Opin Oncol. 2004;16:429\u201335. doi: 10.1097\/00001622-200409000-00003 .","journal-title":"Curr Opin Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9213-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9213-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:22:38Z","timestamp":1559442158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9213-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,14]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9213"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9213-0","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,14]]}}}